...
首页> 外文期刊>Canadian journal of anesthesia: Journal canadien d'anesthesie >Aortic dissection and hypothermic arrest in a Jehovah's Witness patient: a case for recombinant factor VIIa?
【24h】

Aortic dissection and hypothermic arrest in a Jehovah's Witness patient: a case for recombinant factor VIIa?

机译:耶和华见证人患者的主动脉夹层和低温停搏:重组因子VIIa的病例?

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

PURPOSE: To present a case of survival of a cognitively intact Jehovah's Witness patient with an aortic dissection who underwent hypothermic arrest. Recombinant factor VIIa, but no blood products were administered. CLINICAL FEATURES: An 83-yr-old female with an acute type A aortic dissection underwent emergent surgical repair. Proximal extension of the dissection necessitated prolonged cardiopulmonary bypass (CPB) and hypothermic circulatory arrest. Despite this, perioperative hemostatis was adequate. Recombinant factor VIIa 90 microg x kg(-1) i.v. was administered post-CPB. The patient had an uneventful postoperative course, and was discharged home neurologically intact. CONCLUSIONS: Patients who conscientiously object to the transfusion of blood products may present a considerable anesthetic challenge, especially those at risk from coagulopathy associated with CPB and hypothermic circulatory arrest. Recombinant factor VIIa may play a role in hemostasis management of these individuals, however, well-designed randomized controlled trials need to be undertaken to establish the efficacy and risks related to this potential indication.
机译:目的:介绍一名经历过低温停搏的主动脉夹层完好无损的认知完整的耶和华见证人患者。重组因子VIIa,但未施用血液制品。临床特征:一名患有急性A型主动脉夹层的83岁女性接受了紧急手术修复。解剖的近端扩展需要延长体外循环(CPB)和低温循环停止。尽管如此,围手术期止血是足够的。重组因子VIIa 90 microg x kg(-1)i.v.在CPB之后进行管理。该患者术后病程平稳,神经功能完好出院。结论:认真拒绝输血的患者可能会面临很大的麻醉挑战,尤其是那些患有与CPB和低温循环停止相关的凝血病风险的患者。重组因子VIIa可能在这些个体的止血管理中起作用,但是,需要进行精心设计的随机对照试验来确定与这种潜在适应症相关的功效和风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号